Immunohistochemical analysis of patient tumor samples revealed a significant inverse correlation between PLCB4 expression and glioma malignancy (Figure 6C), aligning well with our previous bioinformatic predictions (Figure 3D). This evidence concerns the gene PLCB4 and central nervous system cancer.